Factors associated with rituximab-mediated B cell depletion in ABO-incompatible adult living donor liver transplantation
Background : Pretransplant therapies such as rituximab and plasmapheresis have led to an increase in ABO-incompatible (ABOi) living donor liver transplantation (LDLT), thus helping to overcome organ shortages. This study evaluated the changes in anti-A/B titers and CD19 levels over time in patients...
Sábháilte in:
| Príomhchruthaitheoirí: | , , , , , , , , , , |
|---|---|
| Formáid: | Artigo |
| Teanga: | Inglês |
| Foilsithe / Cruthaithe: |
Korean Society for Transplantation
2023-09-01
|
| Sraith: | Korean Journal of Transplantation |
| Ábhair: | |
| Rochtain ar líne: | http://www.ekjt.org/journal/view.html?doi=10.4285/kjt.23.0031 |
| Clibeanna: |
Níl clibeanna ann, Bí ar an gcéad duine le clib a chur leis an taifead seo!
|